Trastuzumab-related cardiotoxicity in the herceptin adjuvant trial.
Montemurro
Filippo
F
Redana
Stefania
S
Valabrega
Giorgio
G
Martinello
Rossella
R
Aglietta
Massimo
M
Palmiero
Renato
R
D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D017024:Chemotherapy, Adjuvant; D006333:Heart Failure / Q000139:chemically induced; D006801:Humans; D008875:Middle Aged; D000068878:Trastuzumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068878:Trastuzumab